awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37301747-1A634FEE-320D-4138-AA9C-E972CFF9D089
Q37301747-1A634FEE-320D-4138-AA9C-E972CFF9D089
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37301747-1A634FEE-320D-4138-AA9C-E972CFF9D089
Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.
P2860
Q37301747-1A634FEE-320D-4138-AA9C-E972CFF9D089
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37301747-1A634FEE-320D-4138-AA9C-E972CFF9D089
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9922e8ff1232edb5c69b86cac46fe5b386b2b494
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).